Ask the Editor: Method Development
The following question and answer were taken from LCGC Europe's "CE Currents" column (1). How should I approach method development? If possible request any details of sample stability, pKa, and solubility in different solvents and pH ranges. Information on solvents used in HPLC can also be useful.
The following question and answer were taken from LCGC Europe's "CE Currents" column (1).
How should I approach method development?
If possible request any details of sample stability, pKa, and solubility in different solvents and pH ranges. Information on solvents used in HPLC can also be useful.
Initially assess the use of a 1:10 dilution of the running buffer as the optimum choice — this maximizes stacking effects but still maintains stable current traces and avoids the possibility of injection or equipment failures.
A quick test of solvent applicability is to prepare samples in various solvents. A few drops of each sample solution can be added to aliquots of buffer. If the buffer goes cloudy when the drops are added then the sample has precipitated in the buffer and this solvent is probably a poor choice.
(1) K. Altria, LCGC Europe, April 2008.
Questions?
LCGC technical editor Steve Brown will answer your technical questions. Each month, one question will be selected to appear in this space, so we welcome your submissions. Please send all questions to the attention of "Ask the Editor" at lcgcedit@lcgcmag.com We look forward to hearing from you.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
